Soluble T-cell antigen receptor chimeric antigens
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 1, 1993
Grant Date -
N/A
app pub date -
Jan 12, 1990
filing date -
Jan 12, 1990
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Soluble antigens useful for efficient production of antibodies against human T-cell receptor epitopes are provided. A preferred antigen is a chimeric polypeptide comprising at least 100 amino acids from a V.beta. domain with solubility conferred by an immunoglobulin heavy chain CH2 or CH3 domain fused thereto. Product antibodies and methods for diagnostic and therapeutic uses for both antigens and antibodies are provided.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully